{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:06:27Z","timestamp":1790460387863,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>TFE3 Xp11.2 translocation renal cell carcinoma (TFE3-RCC) generally progresses more aggressively compared with other RCC subtypes, but it is challenging to diagnose TFE3-RCC by traditional visual inspection of pathological images. In this study, we collect hematoxylin and eosin- stained histopathology whole-slide images of 74 TFE3-RCC cases (the largest cohort to date) and 74 clear cell RCC cases (ccRCC, the most common RCC subtype) with matched gender and tumor grade. An automatic computational pipeline is implemented to extract image features. Comparative study identifies 52 image features with significant differences between TFE3-RCC and ccRCC. Machine learning models are built to distinguish TFE3-RCC from ccRCC. Tests of the classification models on an external validation set reveal high accuracy with areas under ROC curve ranging from 0.842 to 0.894. Our results suggest that automatically derived image features can capture subtle morphological differences between TFE3-RCC and ccRCC and contribute to a potential guideline for TFE3-RCC diagnosis.<\/jats:p>","DOI":"10.1038\/s41467-020-15671-5","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T10:02:56Z","timestamp":1586858576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Computational analysis of pathological images enables a better diagnosis of TFE3 Xp11.2 translocation renal cell carcinoma"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5493-961X","authenticated-orcid":false,"given":"Jun","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5603-8433","authenticated-orcid":false,"given":"Zhi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6955-8884","authenticated-orcid":false,"given":"Rohit","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9401-1186","authenticated-orcid":false,"given":"Wei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3830-5120","authenticated-orcid":false,"given":"Qianjin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9146-6003","authenticated-orcid":false,"given":"Dong","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8530-370X","authenticated-orcid":false,"given":"Kun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6939-7905","authenticated-orcid":false,"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,14]]},"reference":[{"key":"15671_CR1","unstructured":"Cheng, L., et al. Urologic Surgical Pathology, 4th ed. (Elsevier, 2019)."},{"key":"15671_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.humpath.2019.09.009","volume":"95","author":"GT MacLennan","year":"2020","unstructured":"MacLennan, G. T. & Cheng, L. Five decades of urologic pathology: the accelerating expansion of knowledge in renal cell neoplasia. Hum. Pathol. 95, 24\u201345 (2020).","journal-title":"Hum. Pathol."},{"key":"15671_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","volume":"70","author":"H Moch","year":"2016","unstructured":"Moch, H. et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours. Eur. Urol. 70, 93\u2013105 (2016).","journal-title":"Eur. Urol."},{"key":"15671_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","volume":"23","author":"CJ Ricketts","year":"2018","unstructured":"Ricketts, C. J. et al. The Cancer Genome Atlas comprehensive molecular characterization of renal cell carcinoma. Cell Rep. 23, 313\u2013326.e315 (2018).","journal-title":"Cell Rep."},{"key":"15671_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1053\/j.semdp.2015.02.003","volume":"32","author":"P Argani","year":"2015","unstructured":"Argani, P. MiT family translocation renal cell carcinoma. Semin. Diagn. Pathol. 32, 103\u2013113 (2015).","journal-title":"Semin. Diagn. Pathol."},{"key":"15671_CR6","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1158\/1078-0432.CCR-08-1183","volume":"15","author":"Y Komai","year":"2009","unstructured":"Komai, Y. et al. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clin. Cancer Res. 15, 1170\u20131176 (2009).","journal-title":"Clin. Cancer Res."},{"key":"15671_CR7","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.5858\/arpa.2015-0196-RA","volume":"139","author":"MJ Magers","year":"2015","unstructured":"Magers, M. J. et al. MiT family translocation-associated renal cell carcinoma: a contemporary update with emphasis on morphologic, immunophenotypic, and molecular mimics. Arch. Pathol. Lab. Med. 139, 1224\u20131233 (2015).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"15671_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/nrneph.2017.82","volume":"13","author":"EM Posadas","year":"2017","unstructured":"Posadas, E. M. et al. Targeted therapies for renal cell carcinoma. Nat. Rev. Nephrol. 13, 496\u2013511 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"15671_CR9","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1586\/era.10.72","volume":"10","author":"L Cheng","year":"2010","unstructured":"Cheng, L. et al. Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy. Expert Rev. Anticancer Ther. 10, 843\u2013864 (2010).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"15671_CR10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJMra1601333","volume":"376","author":"TK Choueiri","year":"2017","unstructured":"Choueiri, T. K. & Motzer, R. J. Systemic therapy for metastatic renal-cell carcinoma. N. Engl. J. Med. 376, 354\u2013366 (2017).","journal-title":"N. Engl. J. Med."},{"key":"15671_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.critrevonc.2017.09.011","volume":"119","author":"JM Sanfrancesco","year":"2017","unstructured":"Sanfrancesco, J. M. & Cheng, L. Complexity of the genomic landscape of renal cell carcinoma: Implications for targeted therapy and precision immuno-oncology. Crit. Rev. Oncol. Hematol. 119, 23\u201328 (2017).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"15671_CR12","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S1470-2045(15)00515-X","volume":"17","author":"AJ Armstrong","year":"2016","unstructured":"Armstrong, A. J. et al. Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial. Lancet Oncol. 17, 378\u2013388 (2016).","journal-title":"Lancet Oncol."},{"key":"15671_CR13","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1093\/annonc\/mdt152","volume":"24","author":"J Bellmunt","year":"2013","unstructured":"Bellmunt, J. & Dutcher, J. Targeted therapies and the treatment of non-clear cell renal cell carcinoma. Ann. Oncol. 24, 1730\u20131740 (2013).","journal-title":"Ann. Oncol."},{"key":"15671_CR14","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1002\/cncr.25512","volume":"116","author":"TK Choueiri","year":"2010","unstructured":"Choueiri, T. K. et al. Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma. Cancer 116, 5219\u20135225 (2010).","journal-title":"Cancer"},{"key":"15671_CR15","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1158\/1078-0432.CCR-18-0269","volume":"24","author":"NP Damayanti","year":"2018","unstructured":"Damayanti, N. P. et al. Therapeutic targeting of TFE3\/IRS-1\/PI3K\/mTOR axis in translocation renal cell carcinoma. Clin. Cancer Res. 24, 5977\u20135989 (2018).","journal-title":"Clin. Cancer Res."},{"key":"15671_CR16","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.eururo.2015.10.049","volume":"69","author":"NM Tannir","year":"2016","unstructured":"Tannir, N. M. et al. Everolimus versus sunitinib prospective evaluation in metastatic non-clear cell renal cell carcinoma (ESPN): a randomized multicenter phase 2 trial. Eur. Urol. 69, 866\u2013874 (2016).","journal-title":"Eur. Urol."},{"key":"15671_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/modpathol.2017.99","volume":"31","author":"SL Skala","year":"2018","unstructured":"Skala, S. L. et al. Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays. Mod. Pathol. 31, 179\u2013197 (2018).","journal-title":"Mod. Pathol."},{"key":"15671_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature12222","volume":"499","author":"Cancer Genome Atlas Research Network.","year":"2013","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499, 43\u201349 (2013).","journal-title":"Nature"},{"key":"15671_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1056\/NEJMoa1505917","volume":"374","author":"Cancer Genome Atlas Research Network.","year":"2016","unstructured":"Cancer Genome Atlas Research Network. et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. N. Engl. J. Med. 374, 135\u2013145 (2016).","journal-title":"N. Engl. J. Med."},{"key":"15671_CR20","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/bioinformatics\/btx723","volume":"34","author":"J Cheng","year":"2018","unstructured":"Cheng, J. et al. Identification of topological features in renal tumor microenvironment associated with patient survival. Bioinformatics 34, 1024\u20131030 (2018).","journal-title":"Bioinformatics"},{"key":"15671_CR21","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1158\/0008-5472.CAN-17-0313","volume":"77","author":"J Cheng","year":"2017","unstructured":"Cheng, J. et al. Integrative analysis of histopathological images and genomic data predicts clear cell renal cell carcinoma prognosis. Cancer Res. 77, e91\u2013e100 (2017).","journal-title":"Cancer Res."},{"key":"15671_CR22","doi-asserted-by":"publisher","first-page":"e1001961","DOI":"10.1371\/journal.pmed.1001961","volume":"13","author":"R Natrajan","year":"2016","unstructured":"Natrajan, R. et al. Microenvironmental heterogeneity parallels breast cancer progression: a histology-genomic integration analysis. PLoS Med. 13, e1001961 (2016).","journal-title":"PLoS Med."},{"key":"15671_CR23","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/s41591-019-0508-1","volume":"25","author":"G Campanella","year":"2019","unstructured":"Campanella, G. et al. Clinical-grade computational pathology using weakly supervised deep learning on whole slide images. Nat. Med. 25, 1301\u20131309 (2019).","journal-title":"Nat. Med."},{"key":"15671_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.eswa.2018.09.049","volume":"117","author":"PJ Sudharshan","year":"2019","unstructured":"Sudharshan, P. J. et al. Multiple instance learning for histopathological breast cancer image classification. Expert Syst. Appl 117, 103\u2013111 (2019).","journal-title":"Expert Syst. Appl"},{"key":"15671_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.media.2014.01.010","volume":"18","author":"Y Xu","year":"2014","unstructured":"Xu, Y. et al. Weakly supervised histopathology cancer image segmentation and classification. Med. Image Anal. 18, 591\u2013604 (2014).","journal-title":"Med. Image Anal."},{"key":"15671_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12474","volume":"7","author":"KH Yu","year":"2016","unstructured":"Yu, K. H. et al. Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features. Nat. Commun. 7, 12474 (2016).","journal-title":"Nat. Commun."},{"key":"15671_CR27","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/s41591-019-0462-y","volume":"25","author":"JN Kather","year":"2019","unstructured":"Kather, J. N. et al. Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. Nat. Med. 25, 1054\u20131056 (2019).","journal-title":"Nat. Med."},{"key":"15671_CR28","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/s41591-018-0177-5","volume":"24","author":"N Coudray","year":"2018","unstructured":"Coudray, N. et al. Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning. Nat. Med. 24, 1559\u20131567 (2018).","journal-title":"Nat. Med."},{"key":"15671_CR29","doi-asserted-by":"crossref","unstructured":"Ahmady Phoulady, H. et al. Nucleus segmentation in histology images with hierarchical multilevel thresholding. Medical Imaging 2016: Digital Pathology, (2016).","DOI":"10.1117\/12.2216632"},{"key":"15671_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-015-0055-0","volume":"15","author":"L Xu","year":"2015","unstructured":"Xu, L. et al. Xp11.2 translocation renal cell carcinomas in young adults. BMC Urol. 15, 57 (2015).","journal-title":"BMC Urol."},{"key":"15671_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.humpath.2019.02.008","volume":"87","author":"RF Sharain","year":"2019","unstructured":"Sharain, R. F. et al. Immunohistochemistry for TFE3 lacks specificity and sensitivity in the diagnosis of TFE3-rearranged neoplasms: a comparative, 2-laboratory study. Hum. Pathol. 87, 65\u201374 (2019).","journal-title":"Hum. Pathol."},{"key":"15671_CR32","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/his.13167","volume":"70","author":"M Classe","year":"2017","unstructured":"Classe, M. et al. Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas. Histopathology 70, 1089\u20131097 (2017).","journal-title":"Histopathology"},{"key":"15671_CR33","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1158\/1541-7786.MCR-18-1235","volume":"17","author":"M Baba","year":"2019","unstructured":"Baba, M. et al. TFE3 Xp11.2 translocation renal cell carcinoma mouse model reveals novel therapeutic targets and identifies GPNMB as a diagnostic marker for human disease. Mol. Cancer Res. 17, 1613\u20131626 (2019).","journal-title":"Mol. Cancer Res."},{"key":"15671_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/modpathol.2016.200","volume":"30","author":"A Calio","year":"2017","unstructured":"Calio, A. et al. Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation. Mod. Pathol. 30, 407\u2013415 (2017).","journal-title":"Mod. Pathol."},{"key":"15671_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/cjp2.64","volume":"3","author":"L Cheng","year":"2017","unstructured":"Cheng, L. et al. Fluorescence in situ hybridization in surgical pathology: principles and applications. J. Pathol. Clin. Res 3, 73\u201399 (2017).","journal-title":"J. Pathol. Clin. Res"},{"key":"15671_CR36","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/PAS.0b013e31827e17cb","volume":"37","author":"Q Rao","year":"2013","unstructured":"Rao, Q. et al. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum. Am. J. Surg. Pathol. 37, 804\u2013815 (2013).","journal-title":"Am. J. Surg. Pathol."},{"key":"15671_CR37","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1109\/TMI.2016.2529665","volume":"35","author":"A Vahadane","year":"2016","unstructured":"Vahadane, A. et al. Structure-preserving color normalization and sparse stain separation for histological images. IEEE Trans. Med. Imaging 35, 1962\u20131971 (2016).","journal-title":"IEEE Trans. Med. Imaging"},{"key":"15671_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.media.2017.04.008","volume":"39","author":"A BenTaieb","year":"2017","unstructured":"BenTaieb, A. et al. A structured latent model for ovarian carcinoma subtyping from histopathology slides. Med. Image Anal. 39, 194\u2013205 (2017).","journal-title":"Med. Image Anal."},{"key":"15671_CR39","doi-asserted-by":"publisher","first-page":"e0140381","DOI":"10.1371\/journal.pone.0140381","volume":"10","author":"J Cheng","year":"2015","unstructured":"Cheng, J. et al. Enhanced performance of brain tumor classification via tumor region augmentation and partition. PLoS ONE 10, e0140381 (2015).","journal-title":"PLoS ONE"},{"key":"15671_CR40","doi-asserted-by":"publisher","first-page":"e0157112","DOI":"10.1371\/journal.pone.0157112","volume":"11","author":"J Cheng","year":"2016","unstructured":"Cheng, J. et al. Retrieval of brain tumors by adaptive spatial pooling and fisher vector representation. PLoS ONE 11, e0157112 (2016).","journal-title":"PLoS ONE"},{"key":"15671_CR41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Stat. Methodol. 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol."},{"key":"15671_CR42","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1109\/TPAMI.2005.159","volume":"27","author":"H Peng","year":"2005","unstructured":"Peng, H. et al. Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy. IEEE Trans. Pattern Anal. Mach. Intell. 27, 1226\u20131238 (2005).","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"15671_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-016-1423-9","volume":"18","author":"M Radovic","year":"2017","unstructured":"Radovic, M. et al. Minimum redundancy maximum relevance feature selection approach for temporal gene expression data. BMC Bioinforma. 18, 9 (2017).","journal-title":"BMC Bioinforma."},{"key":"15671_CR44","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1158\/0008-5472.CAN-17-0122","volume":"77","author":"E Rios Velazquez","year":"2017","unstructured":"Rios Velazquez, E. et al. Somatic mutations drive distinct imaging phenotypes in lung cancer. Cancer Res. 77, 3922\u20133930 (2017).","journal-title":"Cancer Res."},{"key":"15671_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/srep38318","volume":"6","author":"Y Xu","year":"2016","unstructured":"Xu, Y. et al. Mal-Lys: prediction of lysine malonylation sites in proteins integrated sequence-based features with mRMR feature selection. Sci. Rep. 6, 38318 (2016).","journal-title":"Sci. Rep."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15671-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15671-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15671-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T23:26:57Z","timestamp":1722727617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15671-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,14]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["15671"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-15671-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,14]]},"assertion":[{"value":"5 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1778"}}